BiomX announces NYSE American acceptance of plan to regain listing compliance

BiomX announced that it received a notification from the NYSE American, dated July 23, 2024, stating that the NYSE American has accepted the Company’s previously submitted plan to regain compliance with the NYSE American’s listing standards. In the Acceptance Letter, the NYSE American confirmed that it has granted the Company until November 23, 2025 to regain compliance with the continued listing standards. As previously disclosed, on May 23, 2024, BiomX received a deficiency letter from the NYSE American indicating that the Company was not in compliance with the NYSE American continued listing standards set forth in Sections 1003(a)(i), (ii) and (iii) of the NYSE American Company Guide.